Clinical and Biochemical Predictors of Mortality in Patients With Decompensated Liver Cirrhosis
European Journal of Clinical Pharmacy · 29.10.2025 · 7 (1) · 9362-9367
DOI: 10.61336/ejcp/25-08-666 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Pharmacy, online erschienen am 29.10.2025.
Abstract (Originalsprache)
Decompensated liver cirrhosis carries a high short-term mortality, driven by a complex interplay of hepatic dysfunction, renal impairment, and systemic complications. Identifying reliable clinical and biochemical predictors of mortality is critical for risk stratification and timely intervention.
Objectives
To identify clinical and biochemical variables that independently predict in-hospital mortality in patients with decompensated liver cirrhosis and to compare the prognostic performance of Child-Turcotte-Pugh (CTP) and Model for End-Stage Liver Disease (MELD) scores.
Methods
This prospective observational study enrolled 35 consecutive patients with decompensated liver cirrhosis admitted to the Department of Medicine, Government Medical College, Satna (M.P.) over a period of 18 months (January 2023 – June 2024). Clinical parameters, biochemical investigations, CTP scores, and MELD scores were recorded at admission. Patients were followed until discharge or death. Statistical analysis included univariate and multivariate logistic regression.
Results
Of 35 patients, 10 (28.6%) died during hospitalization. Non-survivors had significantly higher MELD scores (mean 26.4 ± 4.1 vs. 14.2 ± 3.8; p < 0.001), serum creatinine (3.1 ± 0.9 vs. 1.3 ± 0.4 mg/dL; p < 0.001), total bilirubin (12.6 ± 3.2 vs. 5.1 ± 2.4 mg/dL; p < 0.01), and INR (2.8 ± 0.6 vs. 1.7 ± 0.3; p < 0.001). Hepatic encephalopathy (grade III–IV) and hepatorenal syndrome were the strongest clinical predictors of mortality. MELD score showed superior discriminatory ability (AUROC 0.89) compared to CTP score (AUROC 0.78).
Conclusion
MELD score, serum creatinine, serum bilirubin, INR, and presence of hepatic encephalopathy grade III–IV are significant independent predictors of in-hospital mortality in decompensated liver cirrhosis.
Zitieren
APA
(2025). Clinical and Biochemical Predictors of Mortality in Patients With Decompensated Liver Cirrhosis. European Journal of Clinical Pharmacy, 7(1), 9362-9367. https://doi.org/10.61336/ejcp/25-08-666
Vancouver
Clinical and Biochemical Predictors of Mortality in Patients With Decompensated Liver Cirrhosis. European Journal of Clinical Pharmacy. 2025;7(1):9362-9367. doi:10.61336/ejcp/25-08-666
BibTeX
@article{euvimed2025,
title = {Clinical and Biochemical Predictors of Mortality in Patients With Decompensated Liver Cirrhosis},
journal = {European Journal of Clinical Pharmacy},
year = {2025},
volume = {7},
number = {1},
pages = {9362--9367},
doi = {10.61336/ejcp/25-08-666}
}
EUVIMED